Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


Articles published in Neurobiol Dis

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    June 2017
  1. BARBASH S, Garfinkel BP, Maoz R, Simchovitz A, et al
    Alzheimer's brains show inter-related changes in RNA and lipid metabolism.
    Neurobiol Dis. 2017 Jun 16. pii: S0969-9961(17)30135.
    PubMed     Text format     Abstract available


    April 2017
  2. LE GUENNEC K, Veugelen S, Quenez O, Szaruga M, et al
    Deletion of exons 9 and 10 of the Presenilin 1 gene in a patient with Early-onset Alzheimer Disease generates longer amyloid seeds.
    Neurobiol Dis. 2017 Apr 28. pii: S0969-9961(17)30102.
    PubMed     Text format     Abstract available


    March 2017
  3. CONDELLO C, Stohr J
    Abeta propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.
    Neurobiol Dis. 2017 Mar 27. pii: S0969-9961(17)30062.
    PubMed     Text format     Abstract available


  4. RICHETIN K, Moulis M, Millet A, Arrazola MS, et al
    Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2017 Mar 9. pii: S0969-9961(17)30051.
    PubMed     Text format     Abstract available


    January 2017
  5. WALKER JM, Dixit S, Saulsberry AC, May JM, et al
    Reversal of high fat diet-induced obesity improves glucose tolerance, inflammatory response, beta-amyloid accumulation and cognitive decline in the APP/PSEN1 mouse model of Alzheimer's disease.
    Neurobiol Dis. 2017;100:87-98.
    PubMed     Text format     Abstract available


    October 2016
  6. GRATUZE M, El Khoury NB, Turgeon A, Julien C, et al
    Tau hyperphosphorylation in the brain of ob/ob mice is due to hypothermia: Importance of thermoregulation in linking diabetes and Alzheimer's disease.
    Neurobiol Dis. 2016 Oct 25. pii: S0969-9961(16)30244.
    PubMed     Text format     Abstract available


  7. ANTON-FERNANDEZ A, Aparicio-Torres G, Tapia S, DeFelipe J, et al
    Morphometric alterations of Golgi apparatus in Alzheimer's disease are related to tau hyperphosphorylation.
    Neurobiol Dis. 2016 Oct 25. pii: S0969-9961(16)30245.
    PubMed     Text format     Abstract available


    August 2016
  8. MELNIKOVA T, Park D, Becker L, Lee D, et al
    Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer's disease.
    Neurobiol Dis. 2016 Aug 25. pii: S0969-9961(16)30196.
    PubMed     Text format     Abstract available


  9. IRAM T, Trudler D, Kain D, Kanner S, et al
    Astrocytes from old Alzheimer's disease mice are impaired in Abeta uptake and in neuroprotection.
    Neurobiol Dis. 2016 Aug 17. pii: S0969-9961(16)30193.
    PubMed     Text format     Abstract available


    July 2016
  10. ZENARO E, Piacentino G, Constantin G
    The blood-brain barrier in Alzheimer's disease.
    Neurobiol Dis. 2016 Jul 14. pii: S0969-9961(16)30165.
    PubMed     Text format     Abstract available


    June 2016
  11. HERRING A, Munster Y, Metzdorf J, Bolczek B, et al
    Late running is not too late against Alzheimer's pathology.
    Neurobiol Dis. 2016;94:44-54.
    PubMed     Text format     Abstract available


    May 2016
  12. COMBS B, Hamel C, Kanaan NM
    Pathological conformations involving the amino terminus of tau occur early in Alzheimer's disease and are differentially detected by monoclonal antibodies.
    Neurobiol Dis. 2016 May 31. pii: S0969-9961(16)30119.
    PubMed     Text format     Abstract available


  13. PENG W, Achariyar TM, Li B, Liao Y, et al
    Suppression of glymphatic fluid transport in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2016 May 24. pii: S0969-9961(16)30109.
    PubMed     Text format     Abstract available


  14. KOBRO-FLATMOEN A, Nagelhus A, Witter MP
    Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease.
    Neurobiol Dis. 2016 May 16. pii: S0969-9961(16)30106.
    PubMed     Text format     Abstract available


  15. TANILA H
    The role of BDNF in Alzheimer's disease.
    Neurobiol Dis. 2016 May 13. pii: S0969-9961(16)30102.
    PubMed     Text format    


  16. SOMAVARAPU AK, Kepp KP
    The dynamic mechanism of presenilin-1 function: Sensitive gate dynamics and loop unplugging control protein access.
    Neurobiol Dis. 2016;89:147-56.
    PubMed     Text format     Abstract available


  17. CIMINI S, Sclip A, Mancini S, Colombo L, et al
    The cell-permeable Abeta1-6A2VTAT(D) peptide reverts synaptopathy induced by Abeta1-42wt.
    Neurobiol Dis. 2016;89:101-11.
    PubMed     Text format     Abstract available


    March 2016
  18. SCOTT-MCKEAN JJ, Surewicz K, Choi JK, Ruffin VA, et al
    Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Abeta oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Neurobiol Dis. 2016 Mar 3. pii: S0969-9961(16)30045.
    PubMed     Text format     Abstract available


    February 2016
  19. FOSSATI S, Giannoni P, Solesio ME, Cocklin SL, et al
    The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
    Neurobiol Dis. 2016;86:29-40.
    PubMed     Text format     Abstract available


    January 2016
  20. GIANNONI P, Arango-Lievano M, Neves ID, Rousset MC, et al
    Cerebrovascular pathology during the progression of experimental Alzheimer's disease.
    Neurobiol Dis. 2016 Jan 7. pii: S0969-9961(16)30001.
    PubMed     Text format     Abstract available


    November 2015
  21. MOORE KM, Girens RE, Larson SK, Jones MR, et al
    A spectrum of exercise training reduces soluble Abeta in a dose-dependent manner in a mouse model of Alzheimer's disease.
    Neurobiol Dis. 2015 Nov 9. pii: S0969-9961(15)30083.
    PubMed     Text format     Abstract available


  22. NATUNEN T, Takalo M, Kemppainen S, Leskela S, et al
    Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Neurobiol Dis. 2015 Nov 9. pii: S0969-9961(15)30084.
    PubMed     Text format     Abstract available


    August 2015
  23. HELMFORS L, Boman A, Civitelli L, Nath S, et al
    Protective properties of lysozyme on beta-amyloid pathology; implications for Alzheimer disease.
    Neurobiol Dis. 2015 Aug 31. pii: S0969-9961(15)30044.
    PubMed     Text format     Abstract available


  24. DI MARCO LY, Venneri A, Farkas E, Evans PC, et al
    Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles.
    Neurobiol Dis. 2015 Aug 23. pii: S0969-9961(15)30034.
    PubMed     Text format     Abstract available


  25. PETERS DG, Connor JR, Meadowcroft MD
    The Relationship between Iron Dyshomeostasis and Amyloidogenesis in Alzheimer's Disease: Two Sides of the Same Coin.
    Neurobiol Dis. 2015 Aug 21. pii: S0969-9961(15)30028.
    PubMed     Text format     Abstract available


    July 2015
  26. KEENEY JT, Allan Butterfield D
    Vitamin D Deficiency and Alzheimer Disease: Common Links.
    Neurobiol Dis. 2015 Jul 6. pii: S0969-9961(15)30004.
    PubMed     Text format     Abstract available


  27. VAIKATH NN, Majbour NK, Paleologou KE, Ardah MT, et al
    Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology.
    Neurobiol Dis. 2015;79:81-99.
    PubMed     Text format     Abstract available


    February 2015
  28. STAGNI F, Giacomini A, Guidi S, Ciani E, et al
    Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.
    Neurobiol Dis. 2015;74:204-18.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: